期刊文献+

3种不同survivin基因启动子驱动Apoptin表达的重组慢病毒构建及体外抑瘤效果比较 被引量:2

Construction of three recombinant lentiviruses containing apoptin driven by survivin promoter of different lengths and comparison of their tumor suppressing efficency in vitro
下载PDF
导出
摘要 目的构建3种不同长度的survivin基因启动子融合6×his标签Apoptin cDNA的重组慢病毒载体,经鉴定后行慢病毒包装并感染人结直肠癌细胞(SW480),体外实验观察并比较抑瘤效果。方法克隆3种不同长度的人survivin基因启动子(160、270、987 bp)和Apoptin-6×his cDNA,将其分别连接到pMD18-T载体并在该载体上完成survivin基因启动子和Apoptin基因组装。将组装好的表达盒构建入polyA改造后的慢病毒载体FG12中,利用三质粒包装系统包装成慢病毒。为观察重组慢病毒的抑瘤效果,以最适MOI值感染SW480肿瘤细胞后第5天及第30天,利用AnnexinV-PE/7-AAD凋亡试剂盒和流式细胞术检测细胞凋亡和周期变化,Western blot检测Apoptin-6×his表达。结果成功构建3种重组慢病毒载体,经包装浓缩后获得高滴度病毒,可以有效地感染目的细胞(感染效率大于80%)。体外结果提示病毒感染的SW480可以正确表达Apoptin-6×his蛋白,并能在感染后第30天出现明显的凋亡/坏死。其中,含有270 bp启动子的慢病毒抑瘤作用更为明显。结论采用270 bp survivin启动子,apoptin基因构建的重组慢病毒在靶细胞中显示出较好的抑瘤效果。 Objective To construct the recombinant lentivirus vectors using 3 survivin gene promoters (pSur) with a different length expressing 6 his-tagged apoptin cDNA and observe their tumor-suppressing effect after they were packed and human rectal cancer cells ( SW480 ) were infected with them. Methods Three survivin gene promoters at a length of 160, 270 and 987 bp expressing 6 his-tagged apoptin cDNA were cloned and linked to the pMD18-T vector on which survivin gene promoters and apoptin gene were assembled. The assembled expression box was constructed into the lentivirus vector FG12 modified with polyA. Recombinant lentiviruses were packed using the 3-plasmid packaging system. Tumor-suppressing effect of recombinant ]enti- virus vectors on SW480 cancer cells was observed while apoptosis and cell cycle of SW480 cancer cells were detected by Annexin V-PE/7-AAD and flow cytometry on days 5 and 30 after SW480 cancer cells were infected with recombinant lentiviruses at an optimal MOI. Results The 3 recombinant ]entivirus vectors were success- fully constructed, and high titer lentiviruses were obtained after they were packed and concentrated. The infec- tion rate of target cells for the purified lentivirus was over 80%. In vitro examination showed that the SW480 cancer cells expressed the apoptin protein with apoptosis or necrosis occurred on day 30 after they were infected with recombinant lentivirus. The tumor suppressing effect of recombinant lentivirus containing the 270 bp survivin promoter was more significant. Conclusion Recombinant lentivirus constructed with the 270 bpsurvivin promoter driving apoptin expression in target cells shows a rather good tumor-suppressing effect on human rectal cancer.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第1期39-43,共5页 Journal of Third Military Medical University
基金 重庆市自然科学基金(CSTC2007BA5011)~~
关键词 Apoptin基因 SURVIVIN启动子 慢病毒 肿瘤特异性 apoptin gene lentivirus vector sruvivin promoter tumor specificity
  • 相关文献

参考文献18

  • 1Bruno P,Brinkmann C R,Boulanger M C,et al.Family at last:high-lights of the first international meeting on proteins killing tumour cells[J].Cell Death Differ,2009,16(1):184-186.
  • 2Noteborn M H.Proteins selectively killing tumor cells[J].Eur J Phar-macol,2009,625(1/3):165-173.
  • 3Toscano M G,Romero Z,Munoz P,et al.Physiological and tissue-specific vectors for treatment of inherited diseases[J].Gene Ther,2011,18(2):117-127.
  • 4Kohn D B.Lentiviral vectors ready for prime-time[J].Nat Biotechn-ol,2007,25(1):65-66.
  • 5Levine B L,Humeau L M,Boyer J,et al.Gene transfer in humans u-sing a conditionally replicating lentiviral vector[J].Proc Natl Acad SciU S A,2006,103(46):17372-17377.
  • 6D’Costa J,Mansfield S G,Humeau L M.Lentiviral vectors in clinical tri-als:Current status[J].Curr Opin Mol Ther,2009,11(5):554-564.
  • 7钟波,叶枫,王涛,姜帆,梁后杰,庞学利,邹仲敏.不同活性的survivin基因启动子片段的克隆及鉴定[J].第三军医大学学报,2011,33(11):1115-1118. 被引量:3
  • 8Qin X F,An D S,Chen I S,et al.Inhibiting HIV-1 infection in humanT cells by lentiviral-mediated delivery of small interfering RNA againstCCR5[J].Proc Natl Acad Sci U S A,2003,100(1):183-188.
  • 9Reiser J.Production and concentration of pseudotyped HIV-1-basedgene transfer vectors[J].Gene Ther,2000,7(11):910-913.
  • 10钱倩,王晓通,谢玉波,李雷,肖强.Cdx2基因RNA干扰慢病毒载体的构建与鉴定[J].世界华人消化杂志,2010,18(3):245-249. 被引量:6

二级参考文献34

  • 1白万胜,成诗银,王军利,卞卡,张惠中,刘丽.survivin基因启动子驱动的肿瘤特异性腺病毒载体的构建[J].陕西医学杂志,2008,37(8):959-961. 被引量:2
  • 2郭海霞,李文益,徐令,苏浩彬,黎阳,夏焱,梁立阳.慢病毒载体携带的VEGFR_2 shRNA对HL60的体外杀伤作用[J].中国病理生理杂志,2007,23(6):1053-1057. 被引量:6
  • 3Mutoh H, Sakurai S, Satoh K, Tamada K, Kita H, Osawa H, Tomiyama T, Sato Y, Yamamoto H, Isoda N, Yoshida T, Ido K, Sugano K. Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res 2004; 64: 7740-7747.
  • 4Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 2003; 3: 592-600.
  • 5Arziman Z, Horn T, Boutros M. E-RNAi: a web application to design optimized RNAi constructs. Nucleic Acids Res 2005; 33: W582-W588.
  • 6Baba Y, Nosho K, Shima K, Freed E, Irahara N, Philips J, Meyerhardt JA, Hornick JL, Shivdasani RA, Fuchs CS, Ogino S. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clin Cancer Res 2009; 15: 4665-4673.
  • 7Liu T, Zhang X, So CK, Wang S, Wang P, Yan L, Myers R, Chen Z, Patterson AP, Yang CS, Chen X. Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. Carcinogenesis 2007; 28: 488-496.
  • 8Boudreau F, Rivard N, Gendron FP, Beaulieu JF. [CDX2: a transcription factor with multiple tasks for epithelial cells of the digestive tract] Med Sci (Paris) 2007; 23: 7-8.
  • 9Pushparaj PN, Aarthi JJ, Manikandan J, Kumar SD. siRNA, miRNA, and shRNA: in vivo applications. J Dent Res 2008; 87: 992-1003.
  • 10Noguchi K, Ishitu Y, Kurosaki NM, Takaku H Expression of shRNA using intro splicing. Nucleic Acids Symposium Series 2007; 51: 490-410.

共引文献7

同被引文献21

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部